imaware acquires binx health’s consumer testing business

Print 05 December 2023

imaware, a digital health platform company powering home-testing for healthcare brands, and binx health, a molecular diagnostics and consumer testing company, today announced that imaware has acquired binx health’s at-home consumer testing business. The acquisition will expand imaware’s position in the growing market for home-health testing and expand the number of enterprise clients being serviced by imaware. binx health will retain and continue to grow its point-of-care molecular diagnostics business, which is excluded from the imaware transaction.

Since its creation in 2017, binx health’s consumer division has delivered millions of tests, serviced hundreds of business partners, and generated tens of millions of dollars in revenue. imaware, founded in 2018, offers a broad array of home testing options for employers, health systems, and directly to consumers.

binx health is a healthcare technology and diagnostics company focused on innovating solutions to improve routine testing and convenience, providing timely results to improve patient care. The binx io point-of-care molecular platform is the first ever FDA-cleared, CLIA-waived point-of-care system for the detection of chlamydia and gonorrhea in both males (urine) and females (swab) that provides central lab performance results in about thirty minutes. The binx io platform is highly flexible, easy to use, and enables rapid testing and treatment in a single patient visit.

Source: yahoo!finance

Return